News | Gastrointestinal system diseases

Opinion

Hear it here first: a year of the PJ Pod

During our first full year of The PJ Pod, we explored a range of topics including mental health in the face of COVID-19, hidden disabilities in pharmacy and a closer look at the diversity of the MPharm degree.…

Published: 30 December 2021

News

Return of ranitidine being considered by UK manufacturer

Exclusive: Accord Healthcare is looking into the possibility of bringing back the gastrointestinal drug ranitidine, which has been suspended since November 2020.…

Published: 4 October 2021

Feature

Will ranitidine ever make a comeback? (audio)

We take a closer look at why all licenses for ranitidine were suspended and ask whether it is likely to ever make a comeback.…

Published: 1 October 2021

Feature

Long COVID: the pharmacy staff picking up the pieces months after being infected

We speak to formerly fit and well pharmacists and technicians whose lives have been devastated by long COVID.…

Published: 12 August 2021

Feature

In figures: the science of stress

For many, living through the COVID-19 pandemic will have been the most stressful time in their lives. For some, this stress will have taken a more serious toll, not only on their emotional wellbeing but on their physical health too.…

Published: 22 July 2021

Letter

Specialist pharmacy services must be put in place for patients with IBD

The views expressed in this letter are those of the author’s. If you would like to submit a letter to The Pharmaceutical Journal, please click here. An article published by The Pharmaceutical Journal in April 2021 states correctly that, of the nearly 200 inflammatory bowel disease (I…

Published: 9 July 2021

News

Only 13% of IBD teams meet standards for pharmacist involvement

A report by IBD UK, an alliance of professional bodies, has found that few inflammatory bowel disease services in the UK have enough expert pharmacists.…

Published: 28 April 2021

News

Shortages of alternatives to ranitidine could be putting patients at risk

Pharmacists have reported supply issues with the recommended alternatives to ranitidine, which has been suspended owing to the presence of the contaminant N-Nitrosodimethylamine.…

Published: 6 April 2021

Opinion

Top five infographics of 2020

I’m sure it will come as no surprise that The Pharmaceutical Journal’s most-read infographics this year take a look at COVID-19.…

Published: 22 December 2020

Opinion

What my rollercoaster ride with ‘long COVID’ has taught me about being a pharmacist

At 30 years of age, advanced pharmacist Geraint Jones never imagined a virus could hit him so hard — here, he shares his devastating account of how ‘long COVID’ has affected him, both personally and professionally.…

Published: 16 December 2020